{"id":499,"date":"2024-12-03T08:45:47","date_gmt":"2024-12-03T08:45:47","guid":{"rendered":"https:\/\/en.hengkangpharm.cn\/?page_id=499"},"modified":"2025-10-29T03:08:27","modified_gmt":"2025-10-29T03:08:27","slug":"oligonucleotide-drug-research","status":"publish","type":"page","link":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/","title":{"rendered":"Oligonucleotide Drug Research"},"content":{"rendered":"\n
<\/div><\/span>
\n

Oligonucleotide Drug Research<\/h1>\n\n\n\n
\n<\/div><\/div>\n\n\n\n
\n
\n
\"\u6052\u5eb7LOGO-en\"<\/figure>\n<\/div>\n\n\n\n
\n

Zhejiang Hengkang Pharmaceutical Co., Ltd.<\/strong><\/p>\n\n\n\n

\u6d59\u6c5f\u6052\u5eb7\u836f\u4e1a\u80a1\u4efd\u6709\u9650\u516c\u53f8<\/strong><\/p>\n<\/div>\n<\/div>\n\n\n\n

Oligonucleotide Drug Research<\/strong><\/h2>\n\n\n\n

Oligonucleotide Drug Research<\/h1>\n\n\n\n

Hengkang Pharma provide 90% and 95% or customer purity for all below oligonucleotide, All oliconucleotide only for research and development.
Hengkang Pharma provide siRNA, ASO, etc custom synthesis service.<\/strong><\/p>\n\n\n\n

\n
\n
\n
\n

Bepirovirsen<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aGSK-3228836; IONIS-HBVRx; GSK836<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aBeprovir is an antisense oligonucleotide developed by Ionis Pharmaceuticals Inc. It is a viral protein inhibitor. Currently, the highest development stage of the drug is Phase III clinical trial for the treatment of chronic hepatitis B.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Mipomersen sodium<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aISIS-301012; Kynamro; \u7c73\u6cca\u7f8e\u751f<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aMipomersen sodium is a first-in-class small molecule drug developed by Ionis Pharmaceuticals Inc. It is an APOB inhibitor. Currently, the highest development stage of this drug is withdrawal from the market, and it is used to treat type II hyperlipoproteinemia.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Olpasiran<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aARO-LPA; AMG-890; ARC-LPA; RNAi ARC-LPA<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aOlpasiran is a siRNA developed by Arrowhead Pharmaceuticals Inc and Amgen, and is an Lp(a) inhibitor. Currently, the highest development stage of the drug is Phase III clinical trial, which is used to treat atherosclerosis and atherosclerotic plaques.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Tivanisiran<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aSYL-1001; SYL-1001-DP<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aTivanisiran is a siRNA developed by Sylentis Sa, a TRPV1 antagonist. Currently, the highest development stage of the drug is clinical phase III, which is used to treat Sjogren-Larsson syndrome and dry eye syndrome.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Inclisiran Sodium<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aALN-60212;\u00a0PCSK9si;\u00a0ALN-PCSsc;\u00a0KJX839;\u00a0KJX-839;\u00a0Leqvio;\u00a0\u4e50\u53ef\u4e3a;\u00a0inclisiran;\u00a0\u30a4\u30f3\u30af\u30ea\u30b7\u30e9\u30f3\u30ca\u30c8\u30ea\u30a6\u30e0<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aInksilan sodium is a first-in-class siRNA developed by Alnylam Pharmaceuticals Inc. It is a PCSK9 inhibitor. Currently, the highest development stage of this drug is approval for marketing, which is used to treat hypercholesterolemia, dyslipidemia, carotid artery disease, heterozygous familial hypercholesterolemia and atherosclerosis.
On December 9, 2020, Inxlan sodium was approved by the European Medicines Agency (EMA) and is marketed by Novartis Europharm Ltd under the trade name Leqvio\u00ae. (EMEA\/H\/C\/005333)<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n

Fomivirsen<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aISIS-2922; Vitravene; Fomivirsenum; \u798f\u7c73\u97e6\u751f<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aFomivirsen sodium is an antisense oligonucleotide and a protein biosynthesis inhibitor. Currently, the highest development stage of this drug is withdrawal from the market, and it is used to treat cytomegalovirus retinitis.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Miravirsen<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aSPC-3549; SPC-3649; Miravirsen sodium; Liver-specific microRNA-122 antagonist – Roche; LNA-based miR-122 antagonis; miR-122 antagonist – Roche<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aMiravirsen is an antisense oligonucleotide developed by Roche, which is a hepatitis C virus replication inhibitor and MIRN122 microRNA inhibitor. Currently, the highest development stage of this drug is no progress and it is used to treat chronic hepatitis C and hepatitis C.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Remlarsen<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1aSynthetic miR-29 Mimic; promiR-29; MRG-201; MiR29 replacement; Synthetic microRNA-29 Mimic; Synthetic microRNA29 Mimic; promiR29<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aRemlarsen is a microRNA developed by The University Of Texas Southwestern Medical Center and is a collagen inhibitor. Currently, the highest stage of development of this drug is clinical phase II for the treatment of keloids.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Tofersen<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>Synonym<\/strong><\/strong>\uff1a99mTc-MAG3-BIIB067; ISIS-333611; BIIB-067; SODr\/h333611; ISIS-SOD1Rx; IONIS SOD1Rx; QALSODY; Qalsody; \u51ef\u76db\u8fea<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Description<\/strong>\uff1aTofusen is a first-in-class antisense oligonucleotide developed by Ionis Pharmaceuticals Inc and the Ludwig Institute for Cancer Research. It is a SOD inhibitor. Currently, the highest development stage of this drug is approval for marketing for the treatment of amyotrophic lateral sclerosis.<\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>Packing Size<\/strong>\uff1a100mg \/ 1g \/ 10g<\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Inclisiran Sodium<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\"\"<\/figure><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n

More Information<\/h1>\n\n\n\n
\n
\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n

Business Department<\/h4>\n\n\n\n
<\/div>\n\n\n\n
\n
<\/path><\/svg><\/span>(0086)-576-93233919<\/strong><\/span><\/div>\n\n\n\n
<\/path><\/svg><\/span>bd1@hengkangpharm.cn<\/strong><\/span><\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

Zhejiang Hengkang Pharmaceutical Co., Ltd. \u6d59\u6c5f\u6052\u5eb7\u836f\u4e1a\u80a1\u4efd\u6709\u9650\u516c\u53f8 Oligonucleotide Drug Research Oligonucleotide Drug Research Hengkang Pharma provide 90% and 95% or customer purity for all below oligonucleotide, All oliconucleotide only for research and development.Hengkang Pharma provide siRNA, ASO, etc custom synthesis service. Bepirovirsen Mipomersen sodium Olpasiran Tivanisiran Inclisiran Sodium Fomivirsen Miravirsen Remlarsen Tofersen Inclisiran Sodium More Information […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-499","page","type-page","status-publish","hentry"],"yoast_head":"\nOligonucleotide Drug Research - Zhejiang Hengkang Pharmaceutical<\/title>\n<meta name=\"description\" content=\"Oligonucleotide Drug Research\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oligonucleotide Drug Research - Zhejiang Hengkang Pharmaceutical\" \/>\n<meta property=\"og:description\" content=\"Oligonucleotide Drug Research\" \/>\n<meta property=\"og:url\" content=\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Zhejiang Hengkang Pharmaceutical\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-29T03:08:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"182\" \/>\n\t<meta property=\"og:image:height\" content=\"92\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/\",\"url\":\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/\",\"name\":\"Oligonucleotide Drug Research - Zhejiang Hengkang Pharmaceutical\",\"isPartOf\":{\"@id\":\"https:\/\/en.hengkangpharm.cn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png\",\"datePublished\":\"2024-12-03T08:45:47+00:00\",\"dateModified\":\"2025-10-29T03:08:27+00:00\",\"description\":\"Oligonucleotide Drug Research\",\"breadcrumb\":{\"@id\":\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#primaryimage\",\"url\":\"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png\",\"contentUrl\":\"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png\",\"width\":182,\"height\":92,\"caption\":\"\u6052\u5eb7LOGO-en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/en.hengkangpharm.cn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oligonucleotide Drug Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/en.hengkangpharm.cn\/#website\",\"url\":\"https:\/\/en.hengkangpharm.cn\/\",\"name\":\"Zhejiang Hengkang Pharmaceutical\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/en.hengkangpharm.cn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/en.hengkangpharm.cn\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/en.hengkangpharm.cn\/#organization\",\"name\":\"Zhejiang Hengkang Pharmaceutical\",\"url\":\"https:\/\/en.hengkangpharm.cn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/en.hengkangpharm.cn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2024\/01\/cropped-\u6052\u5eb7-logo-\u7f51\u7ad9200-80px\u526f\u672c-2.png\",\"contentUrl\":\"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2024\/01\/cropped-\u6052\u5eb7-logo-\u7f51\u7ad9200-80px\u526f\u672c-2.png\",\"width\":200,\"height\":67,\"caption\":\"Zhejiang Hengkang Pharmaceutical\"},\"image\":{\"@id\":\"https:\/\/en.hengkangpharm.cn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/zhejiang-hengkang-pharmaceutical-co-ltd\/mycompany\/verification\/?viewAsMember=true\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oligonucleotide Drug Research - Zhejiang Hengkang Pharmaceutical","description":"Oligonucleotide Drug Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/","og_locale":"en_US","og_type":"article","og_title":"Oligonucleotide Drug Research - Zhejiang Hengkang Pharmaceutical","og_description":"Oligonucleotide Drug Research","og_url":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/","og_site_name":"Zhejiang Hengkang Pharmaceutical","article_modified_time":"2025-10-29T03:08:27+00:00","og_image":[{"width":182,"height":92,"url":"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/","url":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/","name":"Oligonucleotide Drug Research - Zhejiang Hengkang Pharmaceutical","isPartOf":{"@id":"https:\/\/en.hengkangpharm.cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#primaryimage"},"image":{"@id":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#primaryimage"},"thumbnailUrl":"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png","datePublished":"2024-12-03T08:45:47+00:00","dateModified":"2025-10-29T03:08:27+00:00","description":"Oligonucleotide Drug Research","breadcrumb":{"@id":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#primaryimage","url":"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png","contentUrl":"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2025\/10\/hklogo.png","width":182,"height":92,"caption":"\u6052\u5eb7LOGO-en"},{"@type":"BreadcrumbList","@id":"https:\/\/en.hengkangpharm.cn\/index.php\/oligonucleotide-drug-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/en.hengkangpharm.cn\/"},{"@type":"ListItem","position":2,"name":"Oligonucleotide Drug Research"}]},{"@type":"WebSite","@id":"https:\/\/en.hengkangpharm.cn\/#website","url":"https:\/\/en.hengkangpharm.cn\/","name":"Zhejiang Hengkang Pharmaceutical","description":"","publisher":{"@id":"https:\/\/en.hengkangpharm.cn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/en.hengkangpharm.cn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/en.hengkangpharm.cn\/#organization","name":"Zhejiang Hengkang Pharmaceutical","url":"https:\/\/en.hengkangpharm.cn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/en.hengkangpharm.cn\/#\/schema\/logo\/image\/","url":"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2024\/01\/cropped-\u6052\u5eb7-logo-\u7f51\u7ad9200-80px\u526f\u672c-2.png","contentUrl":"https:\/\/en.hengkangpharm.cn\/wp-content\/uploads\/2024\/01\/cropped-\u6052\u5eb7-logo-\u7f51\u7ad9200-80px\u526f\u672c-2.png","width":200,"height":67,"caption":"Zhejiang Hengkang Pharmaceutical"},"image":{"@id":"https:\/\/en.hengkangpharm.cn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/zhejiang-hengkang-pharmaceutical-co-ltd\/mycompany\/verification\/?viewAsMember=true"]}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"HengkangPharm","author_link":"https:\/\/en.hengkangpharm.cn\/index.php\/author\/admin\/"},"uagb_comment_info":0,"uagb_excerpt":"Zhejiang Hengkang Pharmaceutical Co., Ltd. \u6d59\u6c5f\u6052\u5eb7\u836f\u4e1a\u80a1\u4efd\u6709\u9650\u516c\u53f8 Oligonucleotide Drug Research Oligonucleotide Drug Research Hengkang Pharma provide 90% and 95% or customer purity for all below oligonucleotide, All oliconucleotide only for research and development.Hengkang Pharma provide siRNA, ASO, etc custom synthesis service. Bepirovirsen Mipomersen sodium Olpasiran Tivanisiran Inclisiran Sodium Fomivirsen Miravirsen Remlarsen Tofersen Inclisiran Sodium More Information…","_links":{"self":[{"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/pages\/499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/comments?post=499"}],"version-history":[{"count":13,"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/pages\/499\/revisions"}],"predecessor-version":[{"id":1636,"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/pages\/499\/revisions\/1636"}],"wp:attachment":[{"href":"https:\/\/en.hengkangpharm.cn\/index.php\/wp-json\/wp\/v2\/media?parent=499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}